News

Fleet Bioprocessing's Director of Chemistry, Chris Blencowe, contributes to " Exploring the versatility of pentafulvene–maleimide cycloaddition as a ligation strategy: buffer and pH effects" published in Organic and Biomolecular Chemistry https://pubs.rsc.org/en/content/articlelanding/2022/OB/D2OB01453J

Fleet Bioprocessing Ltd. are proud to report that following an audit by NQA, we have been recertified to ISO9001: 2015 and ISO13485: 2016 until November 2024.

As Covid-19 restrictions continue in the UK, we are glad to report that Fleet Bioprocessing Ltd. are still able to provide all our usual services. With strict hygiene arrangements and staff working at home wherever possible, we have managed to keep our labs in operation throughout this crisis - with turnaround times close to normal. We look forward to continuing to help our customers through this difficult time.

Fleet Bioprocessing Ltd. are proud to report that we received zero non-conformances in our latest audit against the requirements of ISO9001: 2015 and ISO13485: 2016, which was carried out by NQA in October.

Funded by Innovate UK's Analysis for Innovators programme, Fleet Bioprocessing Ltd. have been collaborating with the National Physical Laboratory and the National Measurement Laboratory (at LGC Ltd.) on a 12-month project investigating the characterisation of antibody conjugates for use in immunoassays. This project has now yielded its first public output: Dr. Luise Luckau from the NML gave a presentation on 10th August 2020 to the Biomacromolecular Structure interest group o

Fleet Bioprocessing Ltd. are pleased to announce that our accreditation to ISO9001: 2015 and ISO13485: 2016 is now being handled by NQA, one of the world's leading certification bodies. You can find our new certificates here . Of course, there will be no change to our existing quality standards, which will always meet the highest industry and regulatory requirements...